Automatically clustered newsroom coverage around one of the most active themes in the intellectual property ecosystem.
IIPLA reviews the patents implications of Patents, Alterity Therapeutics Secures Key, US Patent, with practical notes for global IP teams monitoring risk, enforcement, licensing, and portfolio strategy.
Akebia Therapeutics has been granted a new patent and qualified for a five-year patent term extension on its composition of matter patent for Vafseo® (vadadustat). This development strengthens the company’s intellectual property portfolio and extends market exclusivity for Vafseo®—an oral treatment for anemia due to c…
Subscribe to receive daily and weekly newsroom coverage aligned to this trend cluster and adjacent IP developments.